A carregar...

Proteasome inhibition represses ERα gene expression in ER+ cells- a new link between proteasome activity and estrogen signaling in breast cancer

Estrogen receptor-alpha (ERα) is a major therapeutic target of hormonal therapies in breast cancer and its expression in tumors is predictive of clinical response. Protein levels of ERα are tightly controlled by the 26S proteasome, yet how the clinical proteasome inhibitor, bortezomib, impacts ERα r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Powers, Ginny L., Ellison-Zelski, Stephanie J., Casa, Angelo J., Lee, Adrian V., Alarid, Elaine T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2837136/
https://ncbi.nlm.nih.gov/pubmed/19946334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2009.434
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!